Elvira Umyarova

Elvira Umyarova's work focuses on blood cancers, particularly multiple myeloma and related blood disorders, with an emphasis on patients whose disease has stopped responding to standard drug classes. Much of the research documents real-world treatment outcomes, survival benchmarks, and case reports of rare complications in blood cancer and related conditions, often in collaboration with clinical trial groups. This work is primarily clinical and outcomes-focused, useful for informing treatment decisions and future drug trial design.

Publication output grew from a handful of papers per year in 2017-2018 to a peak in 2022, but has slowed noticeably in the last two years (2024-2025).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026